A detailed history of Blair William & CO transactions in Tilray Brands, Inc. stock. As of the latest transaction made, Blair William & CO holds 153,733 shares of TLRY stock, worth $210,614. This represents 0.0% of its overall portfolio holdings.

Number of Shares
153,733
Previous 153,733 -0.0%
Holding current value
$210,614
Previous $255,000 5.49%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$1.62 - $2.85 $90 - $159
-56 Reduced 0.04%
153,733 $255,000
Q1 2024

May 09, 2024

SELL
$1.6 - $2.48 $7,200 - $11,160
-4,500 Reduced 2.84%
153,789 $379,000
Q4 2023

Feb 12, 2024

SELL
$1.66 - $2.41 $19 - $28
-12 Reduced 0.01%
158,289 $364,000
Q3 2023

Nov 09, 2023

SELL
$1.55 - $3.31 $9 - $19
-6 Reduced -0.0%
158,301 $378,000
Q2 2023

Aug 11, 2023

SELL
$1.52 - $2.78 $22 - $41
-15 Reduced 0.01%
158,307 $246,000
Q1 2023

May 12, 2023

BUY
$2.36 - $3.35 $35 - $50
15 Added 0.01%
158,322 $400,000
Q4 2022

Feb 10, 2023

SELL
$2.58 - $4.68 $3,310 - $6,004
-1,283 Reduced 0.8%
158,307 $425,000
Q3 2022

Nov 09, 2022

BUY
$2.7 - $4.3 $3,618 - $5,762
1,340 Added 0.85%
159,590 $439,000
Q2 2022

Aug 10, 2022

BUY
$3.11 - $7.48 $31,100 - $74,800
10,000 Added 6.75%
158,250 $494,000
Q1 2022

May 13, 2022

BUY
$4.88 - $8.56 $327,887 - $575,146
67,190 Added 82.89%
148,250 $1.15 Million
Q4 2021

Feb 14, 2022

SELL
$7.03 - $13.03 $487,818 - $904,164
-69,391 Reduced 46.12%
81,060 $570,000
Q3 2021

Nov 12, 2021

BUY
$11.11 - $17.84 $146,296 - $234,917
13,168 Added 9.59%
150,451 $1.7 Million
Q2 2021

Aug 12, 2021

BUY
$13.68 - $22.34 $1.88 Million - $3.07 Million
137,283 New
137,283 $2.48 Million

Others Institutions Holding TLRY

About Tilray Brands, Inc.


  • Ticker TLRY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 611,401,984
  • Market Cap $838M
  • Description
  • Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...
More about TLRY
Track This Portfolio

Track Blair William & CO Portfolio

Follow Blair William & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.